Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Leiden Center for Computational Oncology, LUMC, Leiden, The Netherlands.
Histopathology. 2023 Mar;82(4):531-540. doi: 10.1111/his.14849. Epub 2022 Dec 20.
Bone tumours are relatively rare and, as a consequence, treatment in a centre with expertise is required. Current treatment guidelines also recommend review by a specialised pathologist. Here we report on international consensus-based datasets for the pathology reporting of biopsy and resection specimens of bone sarcomas. The datasets were produced under the auspices of the International Collaboration on Cancer Reporting (ICCR), a global alliance of major (inter-)national pathology and cancer organisations.
According to the ICCR's process for dataset development, an international expert panel consisting of pathologists, an oncologic orthopaedic surgeon, a medical oncologist, and a radiologist produced a set of core and noncore data items for biopsy and resection specimens based on a critical review and discussion of current evidence. All professionals involved were bone tumour experts affiliated with tertiary referral centres. Commentary was provided for each data item to explain the rationale for selecting it as a core or noncore element, its clinical relevance, and to highlight potential areas of disagreement or lack of evidence, in which case a consensus position was formulated. Following international public consultation, the documents were finalised and ratified, and the datasets, including a synoptic reporting guide, were published on the ICCR website.
These first international datasets for bone sarcomas are intended to promote high-quality, standardised pathology reporting. Their widespread adoption will improve the consistency of reporting, facilitate multidisciplinary communication, and enhance comparability of data, all of which will help to improve management of bone sarcoma patients.
骨肿瘤相对罕见,因此需要在专业中心进行治疗。目前的治疗指南还建议由专门的病理学家进行审查。本文报告了骨肉瘤活检和切除标本病理报告的国际共识数据集。这些数据集是在国际癌症报告协作组织(ICCR)的主持下生成的,该组织是一个由主要(国际)病理学和癌症组织组成的全球联盟。
根据 ICCR 的数据集开发流程,一个由病理学家、骨肿瘤外科医生、肿瘤内科医生和放射科医生组成的国际专家小组,根据对现有证据的批判性审查和讨论,为活检和切除标本制定了一套核心和非核心数据项。所有参与的专业人员均为与三级转诊中心相关联的骨肿瘤专家。为每个数据项提供了评论,以解释选择其为核心或非核心要素的理由、其临床相关性,并突出潜在的分歧或缺乏证据的领域,在这种情况下,制定了共识立场。在国际公开征求意见后,文件定稿并获得批准,数据集包括一个摘要报告指南,发布在 ICCR 网站上。
这些是首批用于骨肉瘤的国际数据集,旨在促进高质量、标准化的病理报告。它们的广泛采用将提高报告的一致性,促进多学科交流,并提高数据的可比性,所有这些都将有助于改善骨肉瘤患者的管理。